The Bombay High Court on Tuesday granted relief to Cadila Pharmaceuticals Ltd in its plea against Maharashtra food safety regulator’s action against it and remarked that the authority is required to “be judicious” in its actions. The Maharashtra Food and Drug Administration (FDA), under Tukaram Mundhe, had earlier stopped the sale and distribution of some medicines manufactured by Cadila Pharmaceuticals Ltd and seized its stock. Rapping the food safety body, the High Court said that the FDA was only “displaying its powers”. What did Maharashtra food safety body say? Justifying its action against Cadila, the food safety body alleged that its medicines had similar branding despite different active pharmaceutical ingredients (APIs), risking medication errors.